Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Proto Labs IncPRLB · Entity 4553 | President and CEO | February 25, 2025 | February 27, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Proto Labs Inc
Report date February 25, 2025 · Filed February 27, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 108,579 |
Reported balance
After 2025-02-25 transaction · row 1
1 source rowRow 1 · 2025-02-25 · Grant · Acquired 18,935 · Balance 108,579 F1: Restricted Stock Units that vest as follows: 25% of shares subject to the award will vest on February 25, 2026, and on each February 25th thereafter until all shares subject to the award are fully vested. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $39.61 · Expires 2035-02-25 | Direct | 33,986 |
Reported balance
After 2025-02-25 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2025-02-25 · Grant · Acquired 33,986 · Balance 33,986 F2: 25% of shares subject to the award will vest on February 25, 2026, and on each February 25th thereafter until all shares subject to the award are fully vested. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted Stock Units that vest as follows: 25% of shares subject to the award will vest on February 25, 2026, and on each February 25th thereafter until all shares subject to the award are fully vested.
F2: 25% of shares subject to the award will vest on February 25, 2026, and on each February 25th thereafter until all shares subject to the award are fully vested.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 25, 2025 Filed Feb 27, 2025 21:31 UTC | Proto Labs Inc PRLB · Entity 4553 | GrantEmployee Stock Option (right to buy) · Derivative | 33,986 | $0.00 Strike: $39.61 | $0.00 |
DisclosureSEC source: 0001628280-25-008699 · wk-form4_1740691885.xml · derivative · entry 2 Bodor Robert · CIK 0001581088 · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,986 Underlying: Common Stock · 33,986 shares Expires 2035-02-25 F2 · derivative.exercise_date: 25% of shares subject to the award will vest on February 25, 2026, and on each February 25th thereafter until all shares subject to the award are fully vested. Read SEC document |
| February 25, 2025 Filed Feb 27, 2025 21:31 UTC | Proto Labs Inc PRLB · Entity 4553 | GrantCommon Stock | 18,935 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-008699 · wk-form4_1740691885.xml · nonDerivative · entry 1 Bodor Robert · CIK 0001581088 · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 108,579 F1 · shares: Restricted Stock Units that vest as follows: 25% of shares subject to the award will vest on February 25, 2026, and on each February 25th thereafter until all shares subject to the award are fully vested. Read SEC document |
| February 13, 2025 Filed Feb 18, 2025 22:43 UTC | Proto Labs Inc PRLB · Entity 4553 | Tax withholdingCommon Stock | 7,268 | $45.03 | $327,278.04 |
DisclosureSEC source: 0001628280-25-006147 · wk-form4_1739918617.xml · nonDerivative · entry 3 Bodor Robert · CIK 0001581088 · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 89,644 Read SEC document |
| February 13, 2025 Filed Feb 18, 2025 22:43 UTC | Proto Labs Inc PRLB · Entity 4553 | Tax withholdingCommon Stock | 7,536 | $45.03 | $339,346.08 |
DisclosureSEC source: 0001628280-25-006147 · wk-form4_1739918617.xml · nonDerivative · entry 2 Bodor Robert · CIK 0001581088 · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 96,912 Read SEC document |
| February 13, 2025 Filed Feb 18, 2025 22:43 UTC | Proto Labs Inc PRLB · Entity 4553 | GrantCommon Stock | 23,570 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-006147 · wk-form4_1739918617.xml · nonDerivative · entry 1 Bodor Robert · CIK 0001581088 · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 104,448 Read SEC document |
| September 06, 2024 Filed Sep 9, 2024 20:47 UTC | Proto Labs Inc PRLB · Entity 4553 | PurchaseCommon Stock | 3,480 | $28.68 | $99,800.48 |
DisclosureSEC source: 0001628280-24-039901 · wk-form4_1725914871.xml · nonDerivative · entry 1 Bodor Robert · CIK 0001581088 · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,878 F1 · price: Reflects the weighted average price of 3,480 shares of common stock of Proto Labs Inc. purchased by the reporting person in multiple transactions on September 6, 2024, with purchase prices ranging from $28.49 to $29.07 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. F2 · balance_after: Includes 695 shares of Common Stock of the issuer purchased on May 15, 2024 through the issuer's Employee Stock Purchase Plan program. Read SEC document |
| February 13, 2024 Filed Feb 15, 2024 22:03 UTC | Proto Labs Inc PRLB · Entity 4553 | GrantEmployee Stock Option (right to buy) · Derivative | 41,209 | $0.00 Strike: $33.52 | $0.00 |
DisclosureSEC source: 0001437749-24-004394 · rdgdoc.xml · derivative · entry 3 Bodor Robert · CIK 0001581088 · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,209 Underlying: Common Stock · 41,209 shares Expires 2034-02-13 F3 · derivative.exercise_date: 25% of shares subject to the award will vest on February 13, 2025, and on each February 13th thereafter until all shares subject to the award are fully vested. Read SEC document |
| February 13, 2024 Filed Feb 15, 2024 22:03 UTC | Proto Labs Inc PRLB · Entity 4553 | GrantCommon Stock | 22,375 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-004394 · rdgdoc.xml · nonDerivative · entry 2 Bodor Robert · CIK 0001581088 · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 76,703 F2 · shares: Restricted Stock Units that vest as follows: 25% of shares subject to the award will vest on February 13, 2025, and on each February 13th thereafter until all shares subject to the award are fully vested. Read SEC document |
| February 13, 2024 Filed Feb 15, 2024 22:03 UTC | Proto Labs Inc PRLB · Entity 4553 | Tax withholdingCommon Stock | 3,548 | $33.52 | $118,928.96 |
DisclosureSEC source: 0001437749-24-004394 · rdgdoc.xml · nonDerivative · entry 1 Bodor Robert · CIK 0001581088 · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,328 F1 · balance_after: Includes 1,097 shares of Common Stock of the issuer purchased on May 15, 2023 and 1 share of Common Stock of the issuer purchased on November 15, 2023 through the issuer's Employee Stock Purchase Plan program. Read SEC document |
| February 14, 2023 Filed Feb 15, 2023 21:08 UTC | Proto Labs Inc PRLB · Entity 4553 | GrantEmployee Stock Option (right to buy) · Derivative | 10,448 | $0.00 Strike: $33.84 | $0.00 |
DisclosureSEC source: 0001437749-23-003515 · rdgdoc.xml · derivative · entry 5 Bodor Robert · CIK 0001581088 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,448 Underlying: Common Stock · 10,448 shares Expires 2026-02-14 F4 · derivative.exercise_date: The stock option vests in full on February 13, 2024. Read SEC document |
| February 14, 2023 Filed Feb 15, 2023 21:08 UTC | Proto Labs Inc PRLB · Entity 4553 | GrantEmployee Stock Option (right to buy) · Derivative | 42,061 | $0.00 Strike: $33.84 | $0.00 |
DisclosureSEC source: 0001437749-23-003515 · rdgdoc.xml · derivative · entry 4 Bodor Robert · CIK 0001581088 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,061 Underlying: Common Stock · 42,061 shares Expires 2033-02-14 F3 · derivative.exercise_date: 25% of shares subject to the award will vest on February 13, 2024, and on each February 13th thereafter until all shares subject to the award are fully vested. Read SEC document |
| February 14, 2023 Filed Feb 15, 2023 21:08 UTC | Proto Labs Inc PRLB · Entity 4553 | GrantPerformance Stock Units · Derivative | 44,327 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-003515 · rdgdoc.xml · derivative · entry 3 Bodor Robert · CIK 0001581088 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,327 Underlying: Common Stock · 44,327 shares Expires 2025-12-31 F2 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of Proto Labs, Inc. common stock. The performance stock units vest upon Proto Labs, Inc. common stock achieving a specified price per share. F2 · derivative.exercise_date: Each performance stock unit represents a contingent right to receive one share of Proto Labs, Inc. common stock. The performance stock units vest upon Proto Labs, Inc. common stock achieving a specified price per share. Read SEC document |
| February 14, 2023 Filed Feb 15, 2023 21:08 UTC | Proto Labs Inc PRLB · Entity 4553 | GrantCommon Stock | 22,164 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-003515 · rdgdoc.xml · nonDerivative · entry 2 Bodor Robert · CIK 0001581088 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,778 F1 · shares: Restricted Stock Units that vest as follows: 25% of shares subject to the award will vest on February 13, 2024, and on each February 13th thereafter until all shares subject to the award are fully vested. Read SEC document |
| February 13, 2023 Filed Feb 15, 2023 21:08 UTC | Proto Labs Inc PRLB · Entity 4553 | Tax withholdingCommon Stock | 2,053 | $34.23 | $70,274.19 |
DisclosureSEC source: 0001437749-23-003515 · rdgdoc.xml · nonDerivative · entry 1 Bodor Robert · CIK 0001581088 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,614 Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 21:06 UTC | Proto Labs Inc PRLB · Entity 4553 | GrantPerformance Stock Units · Derivative | 23,570 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-003676 · rdgdoc.xml · derivative · entry 3 Bodor Robert · CIK 0001581088 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,570 Underlying: Common Stock · 23,570 shares Expires 2024-12-31 F4 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of Proto Labs, Inc. common stock. The performance stock units vest upon Proto Labs, Inc. common stock achieving a specified price per share. F4 · derivative.exercise_date: Each performance stock unit represents a contingent right to receive one share of Proto Labs, Inc. common stock. The performance stock units vest upon Proto Labs, Inc. common stock achieving a specified price per share. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 21:06 UTC | Proto Labs Inc PRLB · Entity 4553 | GrantEmployee Stock Option (right to buy) · Derivative | 25,147 | $0.00 Strike: $59.40 | $0.00 |
DisclosureSEC source: 0001437749-22-003676 · rdgdoc.xml · derivative · entry 2 Bodor Robert · CIK 0001581088 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,147 Underlying: Common Stock · 25,147 shares Expires 2032-02-13 F3 · derivative.exercise_date: 25% of shares subject to the award will vest on February 13, 2023, and on each February 13th thereafter until all shares subject to the award are fully vested. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 21:06 UTC | Proto Labs Inc PRLB · Entity 4553 | GrantCommon Stock | 11,785 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-003676 · rdgdoc.xml · nonDerivative · entry 1 Bodor Robert · CIK 0001581088 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,667 F1 · shares: Restricted Stock Units that vest as follows: 25% of shares subject to the award will vest on February 13, 2023, and on each February 13th thereafter until all shares subject to the award are fully vested. F2 · balance_after: Reports the total number of shares of Common Stock of the issuer held by the reporting person including 188 shares purchased on May 15, 2021 through the issuer's Employee Stock Purchase Plan program. Read SEC document |
| December 03, 2021 Filed Dec 6, 2021 21:44 UTC | Proto Labs Inc PRLB · Entity 4553 | PurchaseCommon Stock | 3,138 | $47.87 | $150,218.88 |
DisclosureSEC source: 0001437749-21-027938 · rdgdoc.xml · nonDerivative · entry 1 Bodor Robert · CIK 0001581088 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,694 Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 22:51 UTC | Proto Labs Inc PRLB · Entity 4553 | GrantEmployee Stock Option (right to buy) · Derivative | 9,652 | $0.00 Strike: $150.86 | $0.00 |
DisclosureSEC source: 0001437749-21-004880 · rdgdoc.xml · derivative · entry 2 Bodor Robert · CIK 0001581088 · VP/General Manager-Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,652 Underlying: Common Stock · 9,652 shares Expires 2031-03-01 F2 · derivative.exercise_date: The option vests as to 25% of the shares in four annual installments beginning on February 13, 2022. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 22:51 UTC | Proto Labs Inc PRLB · Entity 4553 | GrantCommon Stock | 4,309 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-21-004880 · rdgdoc.xml · nonDerivative · entry 1 Bodor Robert · CIK 0001581088 · VP/General Manager-Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,556 F1 · shares: The restricted stock units vest as to 25% of the shares in four annual installments beginning on February 13, 2022. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 21:43 UTC | Proto Labs Inc PRLB · Entity 4553 | GrantEmployee Stock Option (right to buy) · Derivative | 2,190 | $0.00 Strike: $180.46 | $0.00 |
DisclosureSEC source: 0001437749-21-003286 · rdgdoc.xml · derivative · entry 3 Bodor Robert · CIK 0001581088 · VP/General Manager-Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,190 Underlying: Common Stock · 2,190 shares Expires 2031-02-16 F3 · derivative.exercise_date: The option vests as to 25% of the shares in four annual installments beginning on February 13, 2022. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 21:43 UTC | Proto Labs Inc PRLB · Entity 4553 | GrantCommon Stock | 3,104 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-21-003286 · rdgdoc.xml · nonDerivative · entry 2 Bodor Robert · CIK 0001581088 · VP/General Manager-Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,247 F2 · shares: The restricted stock units vest as to 25% of the shares in four annual installments beginning on February 13, 2022. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 21:43 UTC | Proto Labs Inc PRLB · Entity 4553 | Tax withholdingCommon Stock | 1,337 | $197.05 | $263,455.85 |
DisclosureSEC source: 0001437749-21-003286 · rdgdoc.xml · nonDerivative · entry 1 Bodor Robert · CIK 0001581088 · VP/General Manager-Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,143 F1 · balance_after: Reports the total number of shares of Common Stock of the issuer held by the reporting person including 244 shares purchased on May 15, 2020 and 13 shares purchased on November 15, 2020 through the issuer's Employee Stock Purchase Plan program. Read SEC document |
| April 30, 2020 Filed May 4, 2020 20:10 UTC | Proto Labs Inc PRLB · Entity 4553 | SaleCommon Stock | 3,773 | $109.00 | $411,257.00 |
DisclosureSEC source: 0001437749-20-009262 · rdgdoc.xml · nonDerivative · entry 3 Bodor Robert · CIK 0001581088 · VP/General Manager-Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,223 F1 · kind: Sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 11, 2020. Read SEC document |
| April 30, 2020 Filed May 4, 2020 20:10 UTC | Proto Labs Inc PRLB · Entity 4553 | SaleCommon Stock | 3,118 | $107.00 | $333,626.00 |
DisclosureSEC source: 0001437749-20-009262 · rdgdoc.xml · nonDerivative · entry 2 Bodor Robert · CIK 0001581088 · VP/General Manager-Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,996 F1 · kind: Sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 11, 2020. Read SEC document |
| April 30, 2020 Filed May 4, 2020 20:10 UTC | Proto Labs Inc PRLB · Entity 4553 | SaleCommon Stock | 2,790 | $101.85 | $284,161.50 |
DisclosureSEC source: 0001437749-20-009262 · rdgdoc.xml · nonDerivative · entry 1 Bodor Robert · CIK 0001581088 · VP/General Manager-Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,114 F1 · kind: Sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 11, 2020. Read SEC document |
| February 13, 2020 Filed Feb 18, 2020 21:22 UTC | Proto Labs Inc PRLB · Entity 4553 | Tax withholdingCommon Stock | 1,245 | $100.00 | $124,500.00 |
DisclosureSEC source: 0001437749-20-002917 · rdgdoc.xml · nonDerivative · entry 1 Bodor Robert · CIK 0001581088 · VP/General Manager-Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,904 Read SEC document |
| February 10, 2020 Filed Feb 12, 2020 21:27 UTC | Proto Labs Inc PRLB · Entity 4553 | GrantEmployee Stock Option (right to buy) · Derivative | 3,668 | $0.00 Strike: $96.72 | $0.00 |
DisclosureSEC source: 0001437749-20-002456 · rdgdoc.xml · derivative · entry 2 Bodor Robert · CIK 0001581088 · VP/General Manager-Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,668 Underlying: Common Stock · 3,668 shares Expires 2030-02-10 F3 · derivative.exercise_date: The option vests as to 25% of the shares in four annual installments beginning on February 13, 2021. Read SEC document |
| February 10, 2020 Filed Feb 12, 2020 21:27 UTC | Proto Labs Inc PRLB · Entity 4553 | GrantCommon Stock | 3,071 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-002456 · rdgdoc.xml · nonDerivative · entry 1 Bodor Robert · CIK 0001581088 · VP/General Manager-Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,149 F1 · shares: The restricted stock units vest as to 25% of the shares in four annual installments beginning on February 13, 2021. F2 · balance_after: Reports the total number of shares of Common Stock of the issuer held by the reporting person including 241 shares purchased on May 15, 2018, 55 shares purchased on November 15, 2018, 197 shares purchased on May 15, 2019, and 1 share purchased on November 15, 2019 through the issuer's Employee Stock Purchase Plan program. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 21:07 UTC | Proto Labs Inc PRLB · Entity 4553 | GrantEmployee Stock Option (right to buy) · Derivative | 3,204 | $0.00 Strike: $104.99 | $0.00 |
DisclosureSEC source: 0001437749-19-002461 · rdgdoc.xml · derivative · entry 2 Bodor Robert · CIK 0001581088 · VP/General Manager-Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,204 Underlying: Common Stock · 3,204 shares Expires 2029-02-11 F2 · derivative.exercise_date: The option vests as to 25% of the shares in four annual installments beginning on February 13, 2020. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 21:07 UTC | Proto Labs Inc PRLB · Entity 4553 | GrantCommon Stock | 2,829 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-19-002461 · rdgdoc.xml · nonDerivative · entry 1 Bodor Robert · CIK 0001581088 · VP/General Manager-Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,584 F1 · shares: The restricted stock units vest as to 25% of the shares in four annual installments beginning on February 13, 2020. Read SEC document |
| August 30, 2018 Filed Sep 4, 2018 20:51 UTC | Proto Labs Inc PRLB · Entity 4553 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 907 | $0.00 Strike: $58.35 | $0.00 |
DisclosureSEC source: 0001437749-18-016526 · rdgdoc.xml · derivative · entry 5 Bodor Robert · CIK 0001581088 · VP/General Manager-Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,628 Underlying: Common Stock · 907 shares Expires 2027-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Stock option exercise effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 8, 2018. F5 · derivative.exercise_date: The option vests as to 20% of the shares in five annual installments beginning on February 13, 2018. Read SEC document |
| August 30, 2018 Filed Sep 4, 2018 20:51 UTC | Proto Labs Inc PRLB · Entity 4553 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 3,528 | $0.00 Strike: $78.59 | $0.00 |
DisclosureSEC source: 0001437749-18-016526 · rdgdoc.xml · derivative · entry 4 Bodor Robert · CIK 0001581088 · VP/General Manager-Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,632 Underlying: Common Stock · 3,528 shares Expires 2024-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Stock option exercise effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 8, 2018. F4 · derivative.exercise_date: The option vests as to 20% of the shares in five annual installments beginning on February 13, 2015. Read SEC document |
| August 30, 2018 Filed Sep 4, 2018 20:51 UTC | Proto Labs Inc PRLB · Entity 4553 | SaleCommon Stock | 4,435 | $150.20 | $666,127.24 |
DisclosureSEC source: 0001437749-18-016526 · rdgdoc.xml · nonDerivative · entry 3 Bodor Robert · CIK 0001581088 · VP/General Manager-Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,755 F2 · kind: Sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 8, 2018. F3 · price: Reflects the weighted average price of 4,435 shares of common stock of Proto Labs, Inc. sold by the reporting person on August 30, 2018 with sale prices ranging from $150.00 to $150.70 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 30, 2018 Filed Sep 4, 2018 20:51 UTC | Proto Labs Inc PRLB · Entity 4553 | Exercise / conversionCommon Stock | 907 | $58.35 | $52,923.45 |
DisclosureSEC source: 0001437749-18-016526 · rdgdoc.xml · nonDerivative · entry 2 Bodor Robert · CIK 0001581088 · VP/General Manager-Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,190 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Stock option exercise effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 8, 2018. Read SEC document |
| August 30, 2018 Filed Sep 4, 2018 20:51 UTC | Proto Labs Inc PRLB · Entity 4553 | Exercise / conversionCommon Stock | 3,528 | $78.59 | $277,265.52 |
DisclosureSEC source: 0001437749-18-016526 · rdgdoc.xml · nonDerivative · entry 1 Bodor Robert · CIK 0001581088 · VP/General Manager-Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,283 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Stock option exercise effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 8, 2018. Read SEC document |
| August 23, 2018 Filed Aug 27, 2018 21:04 UTC | Proto Labs Inc PRLB · Entity 4553 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 3,000 | $0.00 Strike: $67.15 | $0.00 |
DisclosureSEC source: 0001437749-18-016197 · rdgdoc.xml · derivative · entry 3 Bodor Robert · CIK 0001581088 · VP/General Manager-Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,998 Underlying: Common Stock · 3,000 shares Expires 2025-02-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Stock option exercise effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 8, 2018. F3 · derivative.exercise_date: The option vests as to 20% of the shares in five annual installments beginning on February 13, 2016. Read SEC document |
| August 23, 2018 Filed Aug 27, 2018 21:04 UTC | Proto Labs Inc PRLB · Entity 4553 | SaleCommon Stock | 3,000 | $145.00 | $435,000.00 |
DisclosureSEC source: 0001437749-18-016197 · rdgdoc.xml · nonDerivative · entry 2 Bodor Robert · CIK 0001581088 · VP/General Manager-Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,755 F2 · kind: Sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 8, 2018. Read SEC document |
| August 23, 2018 Filed Aug 27, 2018 21:04 UTC | Proto Labs Inc PRLB · Entity 4553 | Exercise / conversionCommon Stock | 3,000 | $67.15 | $201,450.00 |
DisclosureSEC source: 0001437749-18-016197 · rdgdoc.xml · nonDerivative · entry 1 Bodor Robert · CIK 0001581088 · VP/General Manager-Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,755 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Stock option exercise effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 8, 2018. Read SEC document |
| June 15, 2018 Filed Jun 19, 2018 20:45 UTC | Proto Labs Inc PRLB · Entity 4553 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,997 | $0.00 Strike: $67.15 | $0.00 |
DisclosureSEC source: 0001437749-18-012074 · rdgdoc.xml · derivative · entry 3 Bodor Robert · CIK 0001581088 · VP/General Manager-Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,998 Underlying: Common Stock · 2,997 shares Expires 2025-02-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vests as to 20% of the shares in five annual installments beginning on February 13, 2016. Read SEC document |
| June 15, 2018 Filed Jun 19, 2018 20:45 UTC | Proto Labs Inc PRLB · Entity 4553 | SaleCommon Stock | 2,997 | $135.10 | $404,904.29 |
DisclosureSEC source: 0001437749-18-012074 · rdgdoc.xml · nonDerivative · entry 2 Bodor Robert · CIK 0001581088 · VP/General Manager-Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,755 F1 · kind: Sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 9, 2017. F2 · price: Reflects the weighted average price of 2,997 shares of common stock of Proto Labs, Inc. sold by the reporting person on June 15, 2018 with sale prices ranging from $135.00 to $135.55 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 15, 2018 Filed Jun 19, 2018 20:45 UTC | Proto Labs Inc PRLB · Entity 4553 | Exercise / conversionCommon Stock | 2,997 | $67.15 | $201,248.55 |
DisclosureSEC source: 0001437749-18-012074 · rdgdoc.xml · nonDerivative · entry 1 Bodor Robert · CIK 0001581088 · VP/General Manager-Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,752 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 12, 2018 Filed Jun 14, 2018 20:32 UTC | Proto Labs Inc PRLB · Entity 4553 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 3,000 | $0.00 Strike: $78.59 | $0.00 |
DisclosureSEC source: 0001437749-18-011837 · rdgdoc.xml · derivative · entry 3 Bodor Robert · CIK 0001581088 · VP/General Manager-Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,160 Underlying: Common Stock · 3,000 shares Expires 2024-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vests as to 20% of the shares in five annual installments beginning on February 13, 2015. Read SEC document |
| June 12, 2018 Filed Jun 14, 2018 20:32 UTC | Proto Labs Inc PRLB · Entity 4553 | SaleCommon Stock | 3,000 | $130.00 | $390,011.70 |
DisclosureSEC source: 0001437749-18-011837 · rdgdoc.xml · nonDerivative · entry 2 Bodor Robert · CIK 0001581088 · VP/General Manager-Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,755 F1 · kind: Sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 9, 2017. F2 · price: Reflects the weighted average price of 3,000 shares of common stock of Proto Labs, Inc. sold by the reporting person on June 12, 2018 with sale prices ranging from $130.00 to $130.10 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 12, 2018 Filed Jun 14, 2018 20:32 UTC | Proto Labs Inc PRLB · Entity 4553 | Exercise / conversionCommon Stock | 3,000 | $78.59 | $235,770.00 |
DisclosureSEC source: 0001437749-18-011837 · rdgdoc.xml · nonDerivative · entry 1 Bodor Robert · CIK 0001581088 · VP/General Manager-Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,755 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 13, 2018 Filed Feb 15, 2018 00:49 UTC | Proto Labs Inc PRLB · Entity 4553 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,891 | $0.00 Strike: $57.88 | $0.00 |
DisclosureSEC source: 0001437749-18-002616 · rdgdoc.xml · derivative · entry 5 Bodor Robert · CIK 0001581088 · VP/General Manager-Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,673 Underlying: Common Stock · 1,891 shares Expires 2026-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The option vests as to 20% of the shares in five annual installments beginning on February 13, 2017. Read SEC document |
| February 13, 2018 Filed Feb 15, 2018 00:49 UTC | Proto Labs Inc PRLB · Entity 4553 | SaleCommon Stock | 1,891 | $106.00 | $200,454.70 |
DisclosureSEC source: 0001437749-18-002616 · rdgdoc.xml · nonDerivative · entry 3 Bodor Robert · CIK 0001581088 · VP/General Manager-Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,755 F3 · kind: Sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 9, 2017. F4 · price: Reflects the weighted average price of 1,891 shares of common stock of Proto Labs, Inc. sold by the reporting person on February 13, 2018 with sale prices ranging from $106.00 to $106.03 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 13, 2018 Filed Feb 15, 2018 00:49 UTC | Proto Labs Inc PRLB · Entity 4553 | Exercise / conversionCommon Stock | 1,891 | $57.88 | $109,451.08 |
DisclosureSEC source: 0001437749-18-002616 · rdgdoc.xml · nonDerivative · entry 2 Bodor Robert · CIK 0001581088 · VP/General Manager-Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,646 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 12, 2018 Filed Feb 15, 2018 00:49 UTC | Proto Labs Inc PRLB · Entity 4553 | GrantEmployee Stock Option (right to buy) · Derivative | 3,004 | $0.00 Strike: $105.75 | $0.00 |
DisclosureSEC source: 0001437749-18-002616 · rdgdoc.xml · derivative · entry 4 Bodor Robert · CIK 0001581088 · VP/General Manager-Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,004 Underlying: Common Stock · 3,004 shares Expires 2028-02-12 F5 · derivative.exercise_date: The option vests as to 25% of the shares in four annual installments beginning on February 13, 2019. Read SEC document |
| February 12, 2018 Filed Feb 15, 2018 00:49 UTC | Proto Labs Inc PRLB · Entity 4553 | GrantCommon Stock | 2,622 | $105.75 | $277,276.50 |
DisclosureSEC source: 0001437749-18-002616 · rdgdoc.xml · nonDerivative · entry 1 Bodor Robert · CIK 0001581088 · VP/General Manager-Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,755 F1 · shares: The restricted stock units vest as to 25% of the shares in four annual installments beginning on February 13, 2019. F2 · balance_after: Reports the total number of shares of Common Stock of the issuer held by the reporting person as of February 14, 2018, including a total of 555 shares of Common Stock of the issuer purchased by the reporting person through the issuer's Employee Stock Purchase Plan program on May 15, 2017 and November 15, 2017. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.